Cannabis Morocco launches nation’s first cannabinoid drug for epilepsy treatment Morocco harvested 294 metric tons of legal cannabis last year Rowan DunneDecember 20, 2024
Medical and Pharmaceutical Krystal Biotech reports success with inhalable lung cancer drug in early-stage trial KB707 demonstrated a 27% objective response rate and 73% disease control rate Rowan DunneDecember 19, 2024
Medical and Pharmaceutical Scientists develop scan technique to light up aggressive lung cancer ‘like a Christmas tree’ More treatment innovation just in time for the holidays Rowan DunneDecember 18, 2024
Medical and Pharmaceutical Cizzle Biotechnology expands lung cancer blood biopsy test distribution into Caribbean This UK oncology company was spun out from the University of York's Department of Biology Rowan DunneDecember 16, 2024
Medical and Pharmaceutical BioAge Labs craters after dropping clinical study on top drug candidate for obesity Usage of the therapeutic resulted in unhealthy levels of transaminases (liver enzymes) in participants Rowan DunneDecember 9, 2024
Medical and Pharmaceutical AI lung cancer screening tech developer, Imidex, seeks buyer at Chicago conference Its 'VisiRad XR' X-ray assessment system is FDA-approved and assisted by Google Cloud's Vertex AI platform Rowan DunneDecember 2, 2024
Health & Wellness India gets much needed lung cancer screening program The nation is facing a lung cancer epidemic from the heavy pollution Rowan DunneNovember 29, 2024
Health & Wellness BC woman advocates for lung cancer screening after shocking diagnosis at 39 Even if you have a healthy lifestyle and don't smoke you should still get checked out, she says Rowan DunneNovember 28, 2024
Medical and Pharmaceutical Kentucky governor recognizes Lung Cancer Awareness Month with formal proclamation Kentucky has the highest rate of the disease in the country, largely attributable to a vast number of smokers Rowan DunneNovember 26, 2024
Medical and Pharmaceutical Neurogene patient dies in drug trial, stock surges after FDA says ‘use lower dose’ This unfortunate incident occurred during a study on the company's Rett syndrome therapeutic NGN-401 Rowan DunneNovember 22, 2024